(Q44971697)

7 December 2017

title

Direct inhibition of EGF receptor activation in vascular endothelial cells by gefitinib ('Iressa', ZD1839). (English)

1 reference

7 December 2017

0 references

Akira Hirata

1

1 reference

7 December 2017

Hisanori Uehara

2

1 reference

7 December 2017

Keisuke Izumi

3

1 reference

7 December 2017

Seiji Naito

4

1 reference

7 December 2017

Michihiko Kuwano

5

1 reference

7 December 2017

Mayumi Ono

6

1 reference

7 December 2017

publication date

1 July 2004

1 reference

7 December 2017

1 reference

7 December 2017

volume

95

1 reference

7 December 2017

issue

7

1 reference

7 December 2017

page(s)

614-618

1 reference

Signal transduction by receptors with tyrosine kinase activity

7 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02496.X

The ErbB signaling network: receptor heterodimerization in development and cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02496.X

The epidermal growth factor receptor family as a central element for cellular signal transduction and diversification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02496.X

The EGF receptor family as targets for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02496.X

Studies leading to the identification of ZD1839 (IRESSA): an orally active, selective epidermal growth factor receptor tyrosine kinase inhibitor targeted to the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02496.X

Tyrosine kinase inhibitors-ZD1839 (Iressa).

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02496.X

The epidermal growth factor receptor and its inhibition in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02496.X

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02496.X

Induction of human microvascular endothelial tubular morphogenesis by human keratinocytes: Involvement of transforming growth factor-α

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02496.X

Epidermal growth factor stimulates vascular endothelial growth factor production by human malignant glioma cells: a model of glioblastoma multiforme pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02496.X

Cell-surface perturbations of the epidermal growth factor and vascular endothelial growth factor receptors by phosphorothioate oligodeoxynucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02496.X

Blockade of epidermal growth factor receptor signaling on tumor cells and tumor-associated endothelial cells for therapy of human carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02496.X

Synergistic effect of TNF-alpha in soluble VCAM-1-induced angiogenesis through alpha 4 integrins

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02496.X

Conditional switching of vascular endothelial growth factor (VEGF) expression in tumors: induction of endothelial cell shedding and regression of hemangioblastoma-like vessels by VEGF withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02496.X

The epidermal growth factor receptor (EGFR): role in corneal wound healing and homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1349-7006.2004.TB02496.X

10.1111/J.1349-7006.2004.TB02496.X

21 January 2018

Identifiers

DOI

1 reference

7 December 2017

1 reference